Nancy Bouchard talks about her experience when her son was fighting cancer, non-Hodgkin’s lymphoma (NHL) Type B:
Dear friends, partners and donors,
When cancer strikes one’s child, isn’t access to the best medications and treatments based on leading-edge technology, delivered by a team of medical experts in the field, the first thing to which we should all be entitled?
Two years ago, my eldest son was fighting cancer, non-Hodgkin’s lymphoma (NHL) Type B, the most common type of lymphoma in the age group of 15-29 years, after Hodgkin’s lymphoma. Although the general public is unaware, NHL is, however, the 5th most common type of cancer in Canada.
A marked increase in the incidence of NHL occurred in young men in the 1980s and 1990s before it declined in 2002, and since then the trend has stabilized. The causes of NHL are still unknown, but the strongest suspects are pesticides and the environment.
Only research will make it possible to identify the causes of this disease and take the measures required to prevent it.
My son was cured thanks to the efforts and resources invested in cancer research over the course of many years. Every day, scientific research gives us a better understanding of the complexity of this disease. Better understanding means adopting increasingly effective methods, better tools, diagnostics and treatments to beat it.
Only research will make it possible to improve the treatment of this disease when it suddenly strikes.
During the Mothers Day season, I urge you to give generously so that local researchers have the tools they need to conduct research on cancer prevention and treatment.
Let’s support research, let’s support our researchers, by giving generously to the Cancer Research Society.
Proud mom of such a courageous, stubborn son